A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

Omada Health shares jumped after the company made its public-market debut, propelled by Americans’ renewed focus on how ...

GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...

Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...

Patients who use GLP1 drugs to help control their type 2 diabetes are at an upward risk of developing age-related macular ...

People taking GLP-1 weight loss medications have found some easy ways to get in lots of protein at meals and snacks.

For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased ...

On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

Two sizable issuers went public this past week and featured the best first-day pop for a billion-dollar IPO in Renaissance’s ...

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in ...